Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Signaling

Background:

• RAF kinases are crucial in cell signaling; their dysregulation causes cancer and developmental disorders.
• Understanding RAF kinase catalytic and allosteric activities, regulated by dimerization, is key for therapeutic strategies.
• Characterizing disease-related RAF mutants requires precise assessment of their functions.

Purpose of the Study:

• To develop practical and sensitive methods for determining RAF kinase catalytic activity, allosteric activity, and dimer affinity/stability.
• To enable accurate characterization of wild-type and mutant RAF proteins.
• To provide tools for selecting targeted therapies for RAF-driven diseases.

Main Methods:

• Modified in vitro kinase assays using reduced detergent and GST fusion to preserve RAF dimers.
• A novel RAF co-activation assay with N-terminal truncated RAF proteins for sensitive allosteric activity measurement.
• A complementary split luciferase assay for quantitative and sensitive assessment of RAF dimer affinity and stability.

Main Results:

• The developed methods accurately measure catalytic activity of constitutively active RAF mutants.
• The RAF co-activation assay enhances sensitivity for evaluating allosteric activity of kinase-dead mutants.
• The split luciferase assay provides a reliable and sensitive alternative to co-immunoprecipitation for measuring RAF dimer interactions.

Conclusions:

• These user-friendly, cost-effective, and highly sensitive methods facilitate the study of RAF family kinases and their mutants.
• The assays enable precise characterization of RAF kinase activities and dimerization.
• These tools support the development of targeted therapeutic strategies for cancers and developmental disorders linked to RAF dysfunction.